Autopsy report · NCT01459796
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Cause of deathNo reason given
Life of this trial
- Registered 1 month before it started.
- Ran for about 1 year 7 months before it stopped.
- 220 participants enrolled.
- Results were posted on the registry 4 years 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Regeneron Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Gout
- Interventions
- Rilonacept; Placebo; Allopurinol
- Participants
- 220
- Sites
- 74
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.